Acute Phase Treatment for Infants Younger Than 1 Year of Age with Kawasaki Disease: A Single Center Retrospective Study
Journal Title: Journal of Advanced Research in Medicine - Year 2019, Vol 6, Issue 1
Abstract
Background: Infants younger than 1 year of age with Kawasaki disease (KD) have a high risk for coronary artery lesions (CAL). However, the appropriate acute phase treatment for the infants has not been established. Objective: To ascertain the usefulness of an initial single intravenous immunoglobulin (IVIG) therapy (2g/ kg) with delayed use of aspirin (DUA) for the infants. Materials and Methods: The outcomes in 205 patients who underwent initial single IVIG therapy at 2g/ kg/ dose with DUA for KD were investigated retrospectively. These subjects were divided into those aged <1 year (infant group, n = 43) and those aged 1 year or older (non-infant group, n=162). Statistical analyses were performed using Stat Flex Version 6 for Windows. Chi-square, Fisher’s exact, and Mann-Whitney U tests were used as appropriate, with sample size considerations. Results: Numbers of major signs in infant group were significantly fewer than those in non-infant group (median 5, interquartile range [IQ]: 5-5 vs. 6, IQ: 5-6, P <0.001). The prevalence of incomplete type (20.9% vs. 11.1%, P=0.091), timing of initial IVIG therapy in regards to day of illness onset (median 5, IQ: 5-6 vs. 5, IQ: 5-6, P=0.452), the prevalence of rescue therapies (9.3% vs. 13.6%, P=0.454), and CAL (0.0% vs. 3.1%, P=0.368) were similar between the 2 groups. No infants received steroids and had the CAL 3mm. The prevalence of initial IVIG therapy resistant patients in infant group was significantly lower than that in non-infant group (9.3% vs. 26.5%, P = 0.017). The defervescence days of illness in infant group were significantly earlier than those in non-infant group (median 6, IQ: 6-7 vs. 7, IQ: 6-8, P <0.001). Conclusion: The infants who are treated appropriately may not have a chance to higher risk of large CAL. An initial single IVIG therapy (2 g/kg) with DUA was useful for prevention of CAL 3 mm in infants with KD.
Authors and Affiliations
Toshimasa Nakada
Keywords
Related Articles
- EP ID EP669836
- DOI 10.24321/2349.7181.201901
- Views 114
- Downloads 0
Clinical Correlates of Hepatitis B or Hepatitis C Coinfections in People Living with HIV/AIDS (PLHIV)
Introduction: Hepatitis B virus (HBV) coinfected HIV patients are likely to have chronic hepatitis B infection and associated severe liver disease, however effect of hepatitis B on HIV has not been proven to be off any e...
A Review on Complications of the Prolonged Use of Proton Pump Inhibitors (PPIs) and Presenting a Case of Barrett’s Esophagus
Background: Gastroesophageal reflux disease (GERD) is the most common among gastric disorders and treated by antacids especially proton pump inhibitors (PPIs). Though symptoms are reported to be controlled by PPIs, howev...
Acute Stroke as the Initial Presentation of Takayasu Arteritis: Rare but Not Infrequent
Takayasu arteritis is an idiopathic, autoimmune, large vessel vasculitis, mainly affecting the young adults. Its exact etiopathogenesis is not known and it has varied clinical presentations.Acute stroke as initial presen...
Overlap Syndrome of Autoimmune Hepatitis and Primary Biliary Cirrhosis: A Clinical Enigma
“Overlap syndrome” is a term used to describe variant forms of autoimmune hepatitis (AIH) which present with characteristics of AIH and primary biliary cirrhosis (PBC) or primary sclerosing cholangitis (PSC). Patients wi...
Hirayama Disease with Rare Presentation in a Young Adult
Hirayama disease or Monomelic Amyotrophy (MMA) is a type of rare cervical myelopathy which is an asymmetrical, self-limited with progressive atrophy and weakness of the muscles of hands and forearms. It is mainly found i...